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Summary Box  34 
What is the key question?  35 
Do associations between birth weight, early childhood growth and lung function change during mid-36 
life to early old age?    37 
What is the bottom line?  38 
Both early childhood growth and birth weight were associated with lung function in middle age, 39 
particularly in women, but the effect size decreased with age and no associations were seen in either 40 
sex in early old age.  41 
Why read on?  42 
This is the first study reporting on whether associations between birth weight and lung function vary 43 
with age within the same individuals with repeated lung function measurements over a 20-year 44 
period.    45 
 46 
Abstract:  47 
Background: Findings from previous studies investigating the relationship between birth weight and 48 
adult lung function have been inconsistent, and data on birth weight and adult lung function decline 49 
are lacking. Few studies have investigated the relation between early childhood growth and adult 50 
lung function.  51 
Methods:  FEV1 and FVC were measured at ages 43, 53 and 60-64 years in the 1946 British birth 52 
cohort study. Multiple linear regression models were fitted to study associations with birth weight 53 
and weight gain at ages 0-2 years. Multilevel models assessed how associations changed with age, 54 
with FEV1 and FVC as repeated outcomes.  55 
Results: 3276 and 3249 participants were included in FEV1 and FVC analyses respectively. In women, 56 
there was a decreasing association between birth weight and FVC with age. From the multilevel 57 
model, for every 1kg higher birth weight, FVC was higher on average by 66.3ml (95%CI: 0.5 to 132) at 58 
43 years, but significance was lost at 53 and 60-64 years.  Similar associations were seen with FEV1, 59 
but linear change (decline) from age 43 years lost statistical significance after full adjustment. In 60 
men, associations with birth weight were null in multilevel models. Higher early life weight gain was 61 
associated with higher FEV1 at age 43 years in men and women combined but not in each sex.  62 
Conclusions: Birth weight is positively associated with adult lung function in middle age, particularly 63 
in women, but the association diminishes with age, potentially due to accumulating environmental 64 
influences over the life course.    65 
Words: 24566 
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INTRODUCTION 67 
Impaired lung function is an important parameter of health and has been found to predict future 68 
morbidity and mortality from both chronic obstructive pulmonary disease (COPD) and coronary 69 
heart disease(1,2), independent of other major risk factors(3). It has been postulated that adverse 70 
“programming”, as a consequence of impaired growth during critical periods in utero and early 71 
childhood, has a lasting effect on both lung function and health more generally in adulthood(4).  72 
Birth weight is often used as an indicator of fetal growth. A meta-analysis of eight studies by Lawlor 73 
et al in 2005 reported that for every 1kg increase in birth weight, FEV1 (Forced Expiratory Volume in 74 
1 second) increased by 48ml (95%CI: 26 to 70)(5). Findings across studies are inconsistent, however, 75 
with some studies reporting an association(6-14), and others not(5,15-18). Six(8,9,11-14) studies adjusted for 76 
potential confounding factors throughout the life course, while four(5,15,16,18) only accounted for a 77 
limited set of potential confounders. All published studies were based on lung function 78 
measurement at a single time point and conducted in different populations at different ages. No 79 
studies to date have investigated whether the relation between birth weight and adult lung function 80 
changes longitudinally with age. Similarly, there is a paucity of data on associations between growth 81 
in early childhood and adult lung function, although two studies have reported positive associations 82 
with weight gain in the first three years of life(13) and in infancy(10), and higher infant weight was 83 
associated with lower mortality from COPD in men in a historical cohort study(6).      84 
The Medical Research Council (MRC) National Survey of Health and Development (NSHD) (1946 85 
British birth cohort) is one of the longest running birth cohorts worldwide with over 20 follow-ups, 86 
including spirometric lung function measurements at ages 43, 53 and 60-64 years(19). We tested 87 
whether the effect of birth weight on adult lung function changes as participants age, controlling for 88 
potential confounders operating through the life course.  89 
  90 
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METHODS 91 
Study population 92 
The NSHD was originally recruited from 16,695 babies who were born in one week of March 1946 in 93 
England, Scotland and Wales(19). All singletons born to married mothers in a non-manual or 94 
agricultural occupational social class and 25% of babies born to a manual social class were selected 95 
as the study sample (N=5362), consisting of 2,547 females and 2,815 males. Cohort members were 96 
interviewed and assessed in their own homes by trained research nurses at ages 43, 53 years and at 97 
clinical research facilities (CRF) (or in their homes) at 60-64 years. At the follow-up in 1989 (aged 43 98 
years), the first year in which FEV1 and FVC (Forced Vital Capacity)  were measured, 3839  of the 99 
original 5362 individuals were eligible for study (365 deaths, 540 refusals,618 emigrations), 3,262 100 
individuals (85%) were contacted and provided data(11) (Figure 1). The most recent follow-up took 101 
place during 2006-10, in which 2,856 individuals of the original sample were invited to a clinic visit 102 
and 2,229 (78%) participants were interviewed by a research nurse at the clinic or in their homes(20).    103 
Spirometry measurements 104 
More information about the spirometry protocol in NSHD is available in the supplementary material 105 
(S1). In brief, at each follow-up, pre- (but not post-) bronchodilator spirometry was carried out 106 
(standing, without nose clips) and supervised by a trained nurse using a Micro Medical Micro Plus 107 
turbine spirometer. The quality of spirometry was assessed by the nurse and formally recorded at 108 
the 1999 and 2006-10 follow-ups. Three manoeuvres were recorded in 1989, and two in 1999 and 109 
2006-10, but otherwise the protocol was the same, which was developed before current ATS/ERS 110 
guidelines were published(21). As with a previous study(22), participants were excluded from the 111 
analysis if the difference between the two largest values was greater than 0.3 litres(23) and if values 112 
were more than 3 standard deviations from the mean value (adjusted for sex and height)(11).    113 
Early life variables 114 
Birth weight to the nearest quarter of a pound was extracted from hospital records within a few 115 
weeks of delivery and converted to kilograms (kg). Weight was measured by health visitors at 2 116 
years and weight gain (g) up to age 2 years was derived by subtracting the birth weight from the 117 
weight at 2 years. Information about lower respiratory tract infections (LRTI) under 2 years was 118 
obtained by interviewing the child’s mother in 1948 and coded as a binary variable (yes vs.no). 119 
Childhood social class at 4 years was defined by father’s occupation (manual vs. non-manual).    120 
Adult variables 121 
Education qualification by aged 26 years was categorised as A-level or equivalent (advanced 122 
secondary qualifications achieved at 18 years) and above, up to O-level or equivalent (secondary 123 
qualifications achieved at 16 years) and less than O-level or no qualifications. Adult standing height 124 
at 43, 53 and 60-64 years was measured to the nearest 0.1cm by using a portable stadiometer. 125 
Current asthma status (yes vs. no) was obtained at every age. Smoking status was obtained at each 126 
interview and expressed as a categorical variable (never, ex-smoker, current smoker) and in ever-127 
smokers, pack-years were also calculated for each age.   128 
Statistical analysis 129 
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3276 and 3249 participants met the inclusion criteria and were included in the FEV1 and FVC 130 
analyses respectively. Mean (SD) lung function for categories of birth weight and current smoking 131 
status at every age was calculated. To assess the relationships between birth weight and 132 
measurements of FEV1 and FVC at every age, multiple linear regression models were fitted, with 133 
models specified a priori. Sex by birth weight interactions were investigated and analyses were 134 
conducted for both sexes and for men and women separately. A sequence of nested models was 135 
fitted: M0-unadjusted model; M1-adjusted for current adult height; M2- further adjusted for current 136 
adult covariates including education level, smoking status, smoking pack years and asthma status; 137 
M3- additionally adjusted for early life covariates including weight gain at 2 years, LRTI under 2 years 138 
and childhood social class (fully adjusted model).  139 
Social class of head of household at every age was added to the fully adjusted model as a sensitivity 140 
analysis to address potential residual confounding by socio-economic status.   141 
In the next step, multilevel models were performed to assess whether the effect of birth weight on 142 
adult lung function changed with increasing age, including a random slope effect for each individual, 143 
hence accounting for the correlation between repeated measures of FEV1 and FVC. Repeated 144 
measures of FEV1 and FVC (level 1 units) were nested within the individual (level 2 units). For each of 145 
FEV1 and FVC, the change in lung function with age was modelled a priori with quadratic as well as 146 
linear terms of age to reflect the expected non-linear change in lung function with increasing age. 147 
The intercept was allowed to vary according to birth weight. Change in lung function was then 148 
allowed to vary according to birth weight by adding an age by birth weight interaction term to the 149 
model. To assess confounding, the adult height was added to the model, followed by adding time-150 
varying adulthood covariates as well as early life covariates.   151 
For both cross-sectional and multilevel models, analyses were also restricted to those with complete 152 
data at every follow-up (complete-case analysis).  153 
Data were analysed using Stata V12.0 statistical package (College Station, Texas, USA). 154 
  155 
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RESULTS 156 
As expected, both mean FEV1 and FVC decreased with increasing age (Table 1) and current smokers 157 
had lower lung function than did the ex-smokers and never smokers at all ages in both sexes. 158 
In analyses of both sexes combined, neither FEV1 nor FVC were associated with birth weight in the 159 
fully adjusted models, except for FVC at age 53 years (Table 2). A test for interaction between birth 160 
weight and sex was statistically significant for FVC at age 53 years (P=0.003) but not at other ages, 161 
and not at any age for FEV1.  162 
In analyses stratified by sex, birth weight was not associated with adult lung function in men at any 163 
age except for FVC at 53 years, where in the fully adjusted model for every 1kg higher in birth 164 
weight, FVC increased by 114ml (95%CI: 19 to 208). However, the association was not consistently 165 
statistically significant across all confounder adjustments (Table 3a). In women, significant 166 
associations between birth weight and both lung function measures were seen at age 43 years in all 167 
models adjusted for adult covariates but not when further adjusted for early life covariates (Table 168 
3b). In fully adjusted models, for every 1 kg increase in birth weight, FEV1 and FVC at 43 years 169 
increased by 51ml (95%CI: -1 to 103) and 64ml (95%CI: -5 to 133) respectively. No statistically 170 
significant associations were seen at age 53 or 60-64 years.  171 
Weight gain up to 2 years of age was significantly associated with slightly higher FEV1 but not FVC at 172 
age 43 years, for both sexes combined (Table 4). In fully adjusted model, each 1kg higher weight gain 173 
up to age 2 years was associated with 17ml (95%CI: 0.7 to 33) higher FEV1 at age 43 years. Significant 174 
associations were not seen at older ages, nor in analyses stratified by sex.  175 
In the multilevel analysis, birth weight had a strong effect in women on both FEV1 and FVC levels at 176 
age 43 years and on the linear change in both measures between 43 and 60-64 years (Table5), with 177 
results showing decreasing size of associations with increasing age. The intercepts were reduced 178 
after adjustments for height, adulthood and early life covariates, but the estimates for linear change 179 
in women remained consistently stable except that the association of birth weight on reduced 180 
decline in FEV1 became non-significant after adjustment for childhood factors. In women, estimates 181 
from the fully adjusted model show that for every 1kg higher birth weight, FEV1 was higher on 182 
average by 61.9ml (95%CI: 11.4 to 112.4) at 43 years,  by 43.9ml (95%CI: -2.8 to 90.6) at 53 years and 183 
25.9 ml (95%CI:  -28.0 to 79.8) at 63 years. Corresponding figures for FVC were 66.3ml (95%CI: 0.5 to 184 
132) at 43 years, 25.7ml (95%CI: -30 to 82) at 53 years and -15ml (95%CI: -82 to 52) at 63 years. The 185 
effect of per 1 kg higher birth weight on adult FVC level decreased by about 80ml in 20 years, thus 186 
supporting the individual regression model results (Table 3b). In men, no changes with age were 187 
observed in terms of effect of birth weight on either FEV1 or FVC.   188 
Sensitivity analyses 189 
Further adjusting for social class of head of household did not materially change the effect estimates 190 
(data not shown). Approximately 50% of the 3262 participants at age 43 years had valid FEV1 191 
(N=1730) and FVC (N=1736) measurements at each of the three ages. There were 626 individuals 192 
who had lung function data at age 43 years but not 53 years, and 919 individuals with data at 53 193 
years but not 60-64 years. A further 454 had missing covariates information giving a sample of 1276 194 
(560 men and 716 women) for complete case analysis. There were no associations found in adjusted 195 
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models between birth weight and both FEV1 and FVC at all ages in men or women in the complete-196 
case analysis (S2a and S2b), while results from the complete-case multilevel model analysis were 197 
broadly comparable to those presented in Table5; in particular the linear change for FEV1 and FVC in 198 
women remained similar (S3).    199 
 200 
 201 
 202 
  203 
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DISCUSSION 204 
To our knowledge, this is the first study to explore the associations between birth weight, early 205 
growth and adult lung function over time with repeated measurements. In women, after adjusting 206 
for adult height and other potential confounders in adult life, higher birth weight remained 207 
positively associated with higher FEV1 and FVC at 43 years; however, the size of the associations 208 
decreased with age in linear regression analyses and this was confirmed in the multilevel analysis. In 209 
men, higher birth weight was only associated with FVC at 53 years after adjustment for adult height 210 
and other confounders and significance was sensitive to confounders included in the model and no 211 
effect was seen in multilevel models. Higher weight gain in early life was only associated with higher 212 
FEV1 at age 43 years in combined analyses but not when stratified by sex, nor at older ages.  213 
Multilevel models using repeated measures allow effective statistical evaluation with missing 214 
outcome data under the assumption that these data are missing at random (MAR)(24). The results 215 
from these analyses suggesting a weakening association with birth weight with age, could 216 
alternatively be interpreted that higher birth weight was associated with faster absolute declines in 217 
FEV1 and FVC in women. Using this interpretation, women with a higher birth weight showed faster 218 
absolute declines in FEV1 than did those with a lower birth weight, by 1.8 ml (95%CI: -0.5to 4.1) per 219 
year per kg higher birth weight, albeit from a higher starting point at age 43 years (FEV1 was higher 220 
by 61.9 ml (95% CI: 11.4 to 112.4) per kg higher birth weight). They also showed a faster decline in 221 
FVC of 4.1ml (95%CI: 0.5 to 7.6) per year per kg higher birth weight. We find this a less intuitive 222 
interpretation than that of a weakening association between birth weight and lung function over 223 
time, particularly as those who were healthier and of higher adult socioeconomic position are more 224 
likely to have remained in the NSHD study over time(25).  225 
We speculate that while early growth is more likely to influence peak attainment of both FEV1 and 226 
FVC as a young adult(26), as life progresses adulthood factors such as smoking, respiratory illness, 227 
body size(27), diet(28) or environmental air pollution(29) start to play greater roles. Additionally, normal 228 
age-related decline in lung function starts in mid-life and the rate rapidly increases as people age(30), 229 
which might also weaken the effect of birth weight on lung function.         230 
Our findings on birth weight and lung function are broadly consistent with previous studies that have 231 
examined individuals at single time points. Most of these studies were in individuals <50 years and 232 
found significant associations between birth weight and either FEV1(8,12,26,31) only or both FEV1 and 233 
FVC(7,9-11,13,14), but some found no associations with either FEV1 or FVC(16-18). Where studies stratified 234 
by sex, two studies in adults aged 20-28 years, found associations with FEV1 in men only(31) in one 235 
study and both sexes in the other(26) but no associations with FVC; two studies of adults with mean 236 
age in the late 40s reported significant positive associations of birth weight with both FEV1 and FVC(7, 237 
9) in both males and females.  Of three studies examining birth weight and lung function at >50 years 238 
of age(5,6,15), two studies did not find an association – a small (N=240) Scottish study(15) with mean 239 
age of 57.6 years and a study of British women aged 60-79 years(5)  – but a study of English males 240 
with mean age of 64 years(6) did. Discrepancies with the present study might arise through 241 
differences in confounder adjustment and cohorts and the small sample size in some other studies.     242 
We stratified the analysis by sex because biological, environmental and sociocultural factors may 243 
affect airway function differentially in males and females across life(32). It is proposed that sex is an 244 
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important determinant of airway diseases and therefore should be considered in both clinical and 245 
epidemiological research(33). Different results in males and females may relate to faster accumulation 246 
of environmental insults in men of this age, such that impact of early life factors would be obscured 247 
in men at a younger age than in women. Men born in 1946 were more likely to (i) smoke (and smoke 248 
heavily) and to be exposed to environmental tobacco smoke and (ii) to have higher occupational 249 
exposures to dust, gases and fumes than  women. We cannot readily explain the isolated significant 250 
association of birth weight with FVC observed in this study in men at age 53 years but this is not 251 
inconsistent with there being a small association across all ages.   252 
Early life growth potentially affects a crucial stage of lung growth and development, and the 253 
numbers of alveoli are known to increase in early life up to around two years of age in both sexes(34). 254 
Few other studies have examined associations between early growth and lung function, with mixed 255 
findings. Similar effect sizes of first year weight gain on both FEV1 and FVC were seen in women age 256 
31 years to those in the present study, but the study also found associations with FVC in men(10).  257 
Another study(13) of 1037 adults aged 32 years found that weight gain by age three years was not 258 
significantly associated with either FEV1 or FVC in combined analysis (men and women), but  FVC was 259 
associated with early weight gain in men only.  260 
A major strength of our study is the regular follow-ups of individuals in this population-based cohort 261 
from birth into late adult life, with data collected on potential confounders and mediating factors 262 
across life, and repeated lung function measurements from mid-life to early old age. The repeated 263 
measures design and hierarchical multilevel modelling approach in the analyses better accounts for 264 
measurement errors and increases power to detect effects.  265 
This study has certain limitations. As with most previous studies, birth weight is the only measure 266 
available as a proxy of fetal growth in this cohort. Hancox reported that BMI at birth or ponderal 267 
index may be slightly better than birth weight as a predictor of lung function at age 32 years(13). 268 
However, in another study, neither birth length nor ponderal index was related to lung function at 269 
age 25 years, but birth weight was(31). Furthermore, the rounding of the original birth weight 270 
measurements may have led to underestimation of associations with lung function, assuming 271 
misclassification of birth weight was random with respect to lung function. Information on 272 
gestational age at birth was not available in 1946, but significant associations remained after 273 
adjusting for gestational age in previous studies(8-10,13,14,31). Also, we have no information on maternal 274 
smoking and dietary patterns across life and during pregnancy, two factors that may impact on fetal 275 
growth(35-36); however, previous studies(8,9) have demonstrated that the explored relationship was 276 
independent of maternal smoking during pregnancy.  Effect estimates were substantially reduced 277 
after adjusting for adult height, an important determinant of adult lung function but also partly 278 
explained by birth weight – babies with higher birth weights became taller adults with bigger 279 
lungs(37).  280 
As expected in a very long-running cohort there was some differential loss over time of participants 281 
with lower educational attainment and lifelong smokers that has been previously 282 
documented(20).This bias might be expected to lead to an underestimate of the overall decline in 283 
lung function and potentially lower accumulation of environmental insults from occupational 284 
sources and active or passive smoking. However, as the NSHD still remains broadly nationally 285 
representative in terms of occupational social class and unemployment profile, we think any impact 286 
10 
 
on the associations presented are likely to be small. Further, the complete-case analysis showed 287 
comparable results for the multilevel models (S3). 288 
In conclusion, our results suggest that while birth weight and early life factors are associated with 289 
lung function in middle age, particularly in women, their impact decreases over time as other risk 290 
factors accumulate over the life course.  291 
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Table 1 Mean (Standard Deviation, SD) of both FEV1 (litres) and FVC (litres) by birth weight (gram) and current smoking status at every age.  300 
 Age 43 years   Age 53 years   Age 60-64 years   
Men  N FEV1 N FVC N FEV1 N FVC N FEV1 N FVC 
Birth weight 1385 3.5(0.6) 1326 4.2(0.8) 1174 3.2(0.6) 1060 4.1(0.7) 856 3.1(0.6) 777 3.9(0.7) 
<2500 g 32 3.3(0.6) 35 3.9(0.9) 33 3.1(0.6) 28 3.8(0.7) 21 2.9(0.6) 22 3.7(0.7) 
2500-3000 g 214 3.3(0.6) 192 4.0(0.7) 168 3.1(0.6) 169 3.9(0.6) 122 3.0(0.6) 107 3.7(0.7) 
3001-3500 g 490 3.5(0.6) 471 4.2(0.8) 397 3.2(0.6) 368 4.1(0.7) 305 3.1(0.5) 274 3.8(0.7) 
3501-4000 g 467 3.5(0.6) 465 4.3(0.8) 411 3.3(0.6) 360 4.2(0.7) 304 3.1(0.6) 281 3.9(0.7) 
>4000 g 182 3.6(0.6) 163 4.4(0.8) 165 3.3(0.6) 135 4.2(0.7) 104 3.2(0.6) 93 3.9(0.8) 
Smoking 1386 3.5(0.6) 1328 4.2(0.8) 1179 3.2(0.6) 1065 4.1(0.7) 782 3.1(0.6) 716 3.9(0.7) 
Never smoker 331 3.5(0.6) 325 4.3(0.8) 292 3.3(0.5) 269 4.1(0.7) 211 3.1(0.5) 193 3.9(0.6) 
Ex-smoker 614 3.6(0.6) 602 4.3(0.8) 598 3.3(0.6) 546 4.1(0.7) 484 3.1(0.6) 452 3.9(0.7) 
Current smoker 441 3.3(0.6) 401 4.0(0.8) 289 3.0(0.5) 250 3.9(0.7) 87 2.7(0.6) 71 3.7(0.7) 
Women N FEV1 N FVC N FEV1 N FVC N FEV1 N FVC 
Birth weight 1451 2.6(0.4) 1448 3.1(0.6) 1218 2.3(0.4) 1175 2.9(0.5) 932 2.2(0.4) 911 2.7(0.5) 
<2500 g 57 2.3(0.4) 58 2.8(0.6) 45 2.2(0.4) 44 2.7(0.4) 30 2.0(0.4) 31 2.4(0.5) 
2500-3000 g 317 2.5(0.4) 324 3.0(0.6) 260 2.3(0.4) 251 2.8(0.5) 189 2.2(0.4) 178 2.7(0.5) 
3001-3500 g 538 2.6(0.4) 541 3.1(0.6) 458 2.3(0.4) 446 2.9(0.5) 354 2.2(0.4) 354 2.7(0.5) 
3501-4000 g 439 2.6(0.4) 424 3.2(0.6) 375 2.4(0.4) 359 2.9(0.5) 284 2.2(0.4) 282 2.8(0.5) 
>4000 g 100 2.6((0.5) 101 3.2(0.6) 80 2.3(0.4) 75 2.8(0.5) 75 2.2(0.4) 66 2.7(0.5) 
Smoking 1456 2.6(0.4) 1452 3.1(0.6) 1223 2.3(0.4) 1180 2.9(0.5) 856 2.2(0.4) 833 2.7(0.5) 
Never smoker 470 2.6(0.4) 474 3.1(0.6) 406 2.4(0.4) 388 2.9(0.5) 300 2.2(0.4) 293 2.7(0.5) 
Ex-smoker 567 2.6(0.4) 569 3.2(0.6) 541 2.4(0.4) 532 2.9(0.5) 475 2.2(0.4) 465 2.7(0.5) 
Current smoker 419 2.4(0.4) 409 3.0(0.6) 276 2.2(0.4) 260 2.7(0.5) 81 1.9(0.4) 75 2.4(0.5) 
 301 
 302 
12 
 
Table 2 Associations (coefficient and 95%CI) between birth weight and both FEV1 (ml) and FVC (ml) at every age in all persons.    303 
 304 
Ϯ: adjusted for age at 2006-10 follow-up (age 60-64 years). 305 
ⱡ: Adult covariates included education level, smoking status, asthma status, smoking pack years.  306 
*: Early life covariates included weight gain at aged 2 years, LRTI under age 2 years,   and childhood social class at age 4 years.  307 
 308 
 309 
 310 
 311 
 312 
 313 
 314 
 315 
 FEV1 (ml)   
Birth weight (per 1kg increase) Age 43 years (N=2836) Age 53 years (N=2392) Age 60-64 years (N=1788) 
M0: unadjusted 247.3 198.7 to 295.8 214.9 163.2 to 266.7 201.7 139.6 to 263.8 
M1: M0+ sex 131.9 94.5 to 169.3 91.9 52.9 to 130.8 106.8 60.3 to 153.2 
M2:M1+adult height Ϯ 39.3 3.8 to 74.9 -2.6 -39.1 to 34.0 6.8 -38.0 to 51.7 
M3: M2+adult covariatesⱡ 25.7 -13.5 to 64.8 17.7 -21.9 to 57.3 22.3 -29.0 to 73.7 
M4: M3+early life covariates* 42.4 -2.3 to 87.0 31.6 -13.3 to 76.5 39.4 -18.1 to 96.8 
 FVC (ml)   
Birth weight (per 1kg increase) Age 43 years (N=2774)   Age 53  years (N=2235)  Age 60-64  years (N=1688) 
M0: unadjusted 330.8 266.5 to 395.0 297.3 227.7 to 366.9 239.8 159.7 to 319.8 
M1: M0+ sex 188.4 137.1 to 239.6 154.4 104.0 to 204.8 112.3 54.2 to 170.4 
M2: M1+adult height Ϯ 59.7 11.3 to 108.1 26.1 -19.6 to 71.8 -31.2 -85.2 to 22.8 
M3: M2+adult covariatesⱡ 34.4 -20.0 to 88.8 37.3 -15.0 to 89.6 -20.4 -84.5 to 43.7 
M4: M3+early life covariates* 43.1 -18.6 to 104.7 60.7 2.1 to 119.3 -13.2 -85.7 to 59.3 
13 
 
Table 3a Associations (coefficient and 95%CI) between birth weight and both FEV1 (ml) and FVC (ml) at age 43, 53 and60-64 years in men.   316 
Men FEV1(ml)   
Birth weight (per 1kg increase) Age 43 years (N=1385) Age 53 years (N=1174) Age 60-64 years (N=856) 
             
M0: unadjusted 128.0 (67.7 to 188.4) 110.7 (49.8 to 171.6) 136.1 (60.6 to 211.6) 
M1: M0+ adult height Ϯ 17.6 (-40.4 to 75.5) 2.1 (-55.6 to 59.7) 8.9 (-64.7 to 82.5) 
M2: M1+adult covariatesⱡ 1.1 (-63.2 to 65.4) 26.3 (-35.6 to 88.2) 27.4 (-55.2 to 109.9) 
M3: M2+early life covariates* 28.4 (-44.9 to 101.7) 34.6 (-35.2 to 104.3) 63.0 (-31.2 to 157.2) 
 FVC(ml)   
Birth weight (per 1kg increase) Age 43 years (N=1326) Age 53 years (N=1060) Age 60-64 years (N=777) 
             
M0: unadjusted 187.7 (103.1 to 272.2) 224.6 (143.8 to 305.5) 128.3 (31.7 to 224.9) 
M1: M0+ adult height Ϯ 30.1 (-50.2 to 110.5) 66.8 (-7.55 to 141.1) -50.5 (-141.2 to 40.3) 
M2: M1+adult covariatesⱡ -3.8 (-95.7 to 88.1) 74.4 (-11.8 to 160.7) -15.3 (-123.2 to 92.6) 
M3: M2+early life covariates* 10.8 (-93.4 to 115.1) 113.6 (19.2 to 208.0) 23.4 (-101.9 to 148.7) 
Ϯ: adjusted for age at 2006-10 follow-up (age 60-64 years). 317 
ⱡ: Adult covariates included education level, smoking status, asthma status, smoking pack years.  318 
*: Early life covariates included weight gain at aged 2 years, LRTI under age 2 years,   and childhood social class at age 4 years.  319 
 320 
 321 
 322 
 323 
 324 
 325 
 326 
 327 
 328 
 329 
 330 
 331 
 332 
 333 
 334 
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Table 3b Associations (coefficient and 95%CI) between birth weight and both FEV1 (ml) and FVC (ml) at age 43, 53 and 60-64 years in women.   335 
Women FEV1 (ml)   
Birth weight (per 1kg increase) Age 43 years (N=1451) Age 53 years (N=1218) Age 60-64 years (N=932) 
             
M0: unadjusted 136.1 (92 to 180.2) 69.4 (21.8 to 117.0) 76.8 (21.8 to 131.7) 
M1: M0+ adult height Ϯ 60.6 (19.3 to 101.9) -10.7 (-55.1 to 33.6) 1.8 (-50.6 to 54.3) 
M2: M1+adult covariatesⱡ 46.8 (1.7 to 92.0)  7.3 (-41.9 to 56.4) 13.7 (-47.7 to 75.2) 
M3: M2+early life covariates* 51.0 (-1.2 to 103.2) 29.9 (-26.3 to 86.1)  19.8 (-47.7 to 87.2) 
 FVC (ml)   
Birth weight (per 1kg increase) Age 43 years  (N=1448) Age 53  years (N=1175) Age 60-64  years (N=911) 
             
M0: unadjusted 189 (129.8 to 248.3) 79.7 (19.2 to 140.2) 96.4 (28.7 to 164) 
M1: M0+ adult height Ϯ 86.8 (31.3 to 142.3) -19.6 (-73.7 to 34.6) -16.9 (-79.0 to 45.1) 
M2: M1+adult covariatesⱡ 63.9 (2.6 to 125.1) -4.5 (-66.2 to 57.2) -23.1 (-96.0 to 49.9) 
M3: M2+early life covariates* 64.2 (-5.0 to 133.3) 2.3 (-68.3 to 72.9) -31.4 (-111.7 to 49.0) 
Ϯ: adjusted for age at 2006-10 follow-up (age 60-64 years). 336 
ⱡ: Adult covariates included education level, smoking status, asthma status, smoking pack years.  337 
*: Early life covariates included weight gain at aged 2 years, LRTI under age 2 years,   and childhood social class at age 4 years.  338 
 339 
 340 
 341 
 342 
 343 
 344 
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Table 4 Associations (coefficient and 95%CI) between weight gain up to aged 2 years and both FEV1 (ml) and FVC (ml) at age 43, 53 and 60-64 years in men and women: fully adjusted 345 
model*.  346 
All persons  
 
FEV1(ml) 
Weight gain up to 2 years of age   
(per 1kg increase) 
Age 43 years (N=2836) Age 53 years (N=2392) Age 60-64 years (N=1788) 
 17.1 0.7 to 33.5 4.8 -11.7 to 21.3 10.8 -9.0 to 30.6 
 FVC(ml) 
Weight gain up to 2 years of age   
(per 1kg increase) 
Age 43 years (N=2774)   Age 53 years (N=2235) Age 60-64 years (N=1688) 
 10.6 -11.8 to 33.1 13.0 -8.0 to 34.0 1.4 -23.9 to 26.7 
Men FEV1(ml)   
Weight gain up to 2 years of age   
(per 1kg increase) 
Age 43 years (N=1385) Age 53 years (N=1174) Age 60-64 years (N=856) 
 20.3 (-7.2 to 47.7) -3.6 (-30.0 to 22.9) 30.9 (-2.7 to 64.6) 
 FVC(ml)   
Weight gain up to 2 years of age   
(per 1kg increase) 
Age 43 years (N=1326) Age 53 years (N=1060) Age 60-64 years (N=777) 
 2.5 (-35.4 to 40.4) 24.5 (-9.8 to 58.8) 34.7 (-11.8 to 81.3) 
 347 
 348 
Women FEV1 (ml)   
Weight gain up to 2 years of age   
(per 1kg increase) 
Age 43 years (N=1451) Age 53 years (N=1218) Age 60-64 years (N=932) 
 15.6 (-3.1 to 34.3) 13.4 (-6.4 to 33.1) -1.0 (-23.2 to 21.2) 
 FVC (ml)   
Weight gain up to 2 years of age   
(per 1kg increase) 
Age 43 years  (N=1448) Age 53  years (N=1175) Age 60-64  years (N=911) 
 23.6 (-1.5 to 48.8) 5.8 (-19.0 to 30.6) -15.5 (-41.9 to 10.9) 
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*fully adjusted model: height, adult covariates included education level, smoking status, asthma status, smoking pack years; early life covariates included birth weight, LRTI under age 2 years,  and childhood social 349 
class at age 4 years; adjusted additionally for age at 2006-10 follow-up (aged 60-64 years). 350 
Table 5 Associations (coefficient and 95%CI) between birth weight and FEV1 (ml) and FVC (ml) change from ages 43 years to 60-64 years (multilevel model). 351 
 FEV1 (N=1640) FVC (N=1609) 
Men Age 43 years 
 (ml)  
Linear change from age 43 
years, (ml/year),  
Age 43 years (ml)  Linear change from age 43 
years, (ml/year)   
Birth weight(per 1kg increase)                 
M0: age, quadratic age, 
age*birth weight 
131.6 (75.6 to 187.6) 0.3  (-2.2 to 2.8) 198.2 (119.6 to 276.8) -1.1 (-5.5 to 3.3) 
M1: M0+ adult height 31.9 (-21.4 to 85.2) 0.2 (-2.4 to 2.7) 50.3 (-23.7 to 124.3) -1.8 (-6.2 to 2.6) 
M2: M1+adult covariatesⱡ 24.7 (-35.3 to 84.8) 2.0 (-0.9 to 5.0) 18.6 (-66.7 to 103.8) 2.0 (-3.1 to 7.1) 
M3: M2+ early life covariates* 50.0 (-17.5 to 117.6) 1.9 (-1.4 to 5.2) 42.9 (-52.4 to 138.1) 2.4 (-3.4 to 8.1) 
ⱡ: Adult covariates included education level, smoking status, asthma status, smoking pack years.  352 
*: Early life covariates included weight gain at age 2 years, LRTI under age 2 years,   and childhood social class at age 4 years. 353 
 FEV1 (N=1636) FVC (N=1640) 
Women Age 43 years 
 (ml)  
Linear change from age 43 
years, (ml/year),  
Age 43 years (ml)  Linear change from age 43 
years, (ml/year)   
Birth weight(per 1kg increase)                 
M0:  age, quadratic age, 
age*birth weight 
131.4 (88.7 to 174.0) -2.5 (-4.3 to -0.7) 184.4 (127.4 to 241.3) -4.5 (-7.2 to -1.7) 
M1: M0+ adult height 60.6 (21.0 to 100.1) -2.6 (-4.4 to -0.8) 81.4 (28.9 to 134.0) -5.0 (-7.8 to -2.3) 
M2: M1+adult covariatesⱡ 58.0 (13.7 to 102.4) -2.4 (-4.5 to -0.3) 69.0 (10.1 to 127.9) -4.8 (-7.9 to -1.5) 
M3: M2+ early life covariates* 61.9 (11.4 to 112.4) -1.8 (-4.1 to 0.5) 66.3 (0.5 to 132.1) -4.1 (-7.6 to -0.5) 
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Figures legends 433 
Figure 1: Flowchart of participation in NSHD study  434 
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